(Q33893317)

29 July 2017

1 reference

title

Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock (English)

1 reference

acute respiratory distress syndrome

29 July 2017

0 references

1 reference

1 reference

1 reference

Fein AM

1

1 reference

29 July 2017

Calalang-Colucci MG

series ordinal

2

1 reference

29 July 2017

publication date

1 April 2000

1 reference

29 July 2017

published in

Critical Care Clinics

1 reference

29 July 2017

volume

16

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

289-317

1 reference

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Acute respiratory distress in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Multiple organ system failure and infection in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Short-term effects of prone position in critically ill patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Prone position in mechanically ventilated patients with severe acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Markers for predicting the development of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Endotoxemia in human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Placebo and inhaled nitric oxide mortality the same in ARDS clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Mechanisms of the adult respiratory distress syndrome: selectins

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Role of selectiris In development of adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Identification of patients with acute lung injury. Predictors of mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The value of edema fluid protein measurement in patients with pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The risk factors, incidence, and prognosis of ARDS following septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Is outcome from ARDS related to the severity of respiratory failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Improved oxygenation using the prone position in patients with ARDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Adult respiratory distress syndrome: risk with common predispositions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Impairment after adult respiratory distress syndrome. An evaluation based on American Thoracic Society recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Ethanol ingestion impairs alveolar epithelial glutathione homeostasis and function, and predisposes to endotoxin-mediated acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Infections and the inflammatory response in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Clinical risks for development of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Tumor Necrosis Factor Levels in Serum and Bronchoalveolar Lavage Fluid of Patients with the Adult Respiratory Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Effect of granulocyte depletion in a ventilated surfactant-depleted lung

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Evaluation of definitions for adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Effectiveness of nitric oxide inhalation in septic ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The prone position in ARDS patients. A clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Acute lung injury and the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Gram-Negative Sepsis and the Adult Respiratory Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Lung cytokines and ARDS: Roger S. Mitchell Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Recovery of function in survivors of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The Role of Chronic Alcohol Abuse in the Development of Acute Respiratory Distress Syndrome in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

An expanded definition of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Clinical predictors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Incidence of pulmonary barotrauma in a medical ICU

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Use of extreme position changes in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Biological markers of acute lung injury: prognostic and pathogenetic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Cardiorespiratory effects of positive end-expiratory pressure during progressive tidal volume reduction (permissive hypercapnia) in patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

A dual-binding antibody to E- and L-selectin attenuates sepsis-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Adult respiratory-distress syndrome: changing concepts of lung injury and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Epidemiology of sepsis syndrome in 8 academic medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Mechanical ventilation of patients with acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Current concepts of sepsis and acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Ketoconazole prevents acute respiratory failure in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Lung injury caused by mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Permissive hypercapnic ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units. An international, multicenter, prospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The incidence of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Stress failure of pulmonary capillaries as a limiting factor for maximal exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970111-1

7 January 2021

10.1016/S0749-0704(05)70111-1

Identifiers

DOI

1 reference

29 July 2017

1 reference